Clinical Trials Browser

Phase 1/2 × Chemoradiotherapy × Thoracic × Clear all

NCT04958993 2022-02-25

A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung